Asset 6_15x.png

Program

Nordic Psychedelic Science Conference offers a two day academic program on the past, present and future of psychedelic science. You will hear from Nordic and international experts within the field.

 
background_gradient.png

Thursday May 19

Friday May 20

Friday May 20

background_gradient.png

DAY 1

08.15 - 08.45

ENTRANCE

Registration 

09.00 - 10.20

MAIN STAGE

Welcome
by Anna Høifødt

A historical perspective on psychedelics in Norway

by Professor Willy Pedersen

Drugs vs. medicine, a framework for discussion
by Dr. Andreas Wahl Blomkvist

The Bioethics of Psychedelics
by Professor Ole Martin Moen

10.20 - 10.40

BREAK

Coffee, tea, fruit & snacks

10.40 - 11.45

MAIN STAGE

Mechanisms of psychedelics in the brain
by Dr. Dea Siggard Stenbæk

Immune and anti-inflammatory effects of psychedelics
by Atila Szabo PhD

MDMA-assisted therapy for depression
by Dr. Tor-Morten Kvam

11.45 - 13.00

BREAK

Lunch

13.00 - 14.10

MAIN STAGE

Psilocybin for treatment-resistant depression
by Professor Rasmus Licht

Short introduction of the PSIPET study and a novel approach to group treatment with psilocybin for young adults with depression.

by Dr Eva Henje PhD

Psilocybin assisted therapy for alcohol use disorder
by Dr Mathias Ebbesen Jensen

14.10 - 14.30

BREAK

Coffee, tea, fruit & snacks

14.30 - 15.20

MAIN STAGE

Ketamine for addiction
by Professor Celia Morgan

Psilocybin assisted therapy for anorexia nervosa
by Dr David Erritzoe

 

A patient perspective
by Guro Skottene

DAY 2

08.30 - 09.00

ENTRANCE

Doors open

09.00 - 10.20

MAIN STAGE

Implementation Roadmap for MDMA Assisted Therapy for PTSD
by Amy Emerson

Compass 2b clinical trials results
with Dr. Danielle Schlosser 

Panel: Challenges to implementation

with Amy Emerson, Dr. Danielle Schlosser, Dr. Lowan Stewart & Dr. Ingmar Clausen. Moderated by Filip Bromberg

10.20 - 10.40

BREAK

Coffee, tea, fruit & snacks

10.40 - 12.00

MAIN STAGE

Have Norwegians tried psilocybin, and do they accept it as a medicine

by Dr. Henrik Børsting Jacobsen

Classic psychedelics and potential risks: an epidemiological perspective​

 by Otto Simonsson Post. doc

 

Challenges in psychedelic science
 by Kristoffer Andersen 

12.00 - 13.00

BREAK

Lunch

13.00 - 14.00

MAIN STAGE

Integration therapy and the psychedelic therapist
by Ivar Goksøyr

 

Panel: The psychedelic therapist With Johan Eriksson, Ivar Goksøyr, Tor-Morten Kvam, Dea Siggaard Stenbæk and Anders Thingmand. Moderated by Kristoffer Andersen

14.00 - 14.20

BREAK

Coffee, tea, fruit & snacks

14.20 - 15.20

MAIN STAGE

The Importance of Bodyset in The Psychedelic Experience and Beyond
by Malin Uthaug PhD

Sound, intensity and holding​

by Bolette Daniels Beck AP, PhD

Evening symposium

Doors open & registration

19.00 - 19.20

Psychedelics in psychiatry, from micro to macro doses

The effects of DMT - A peculiar experiment in Swedish television (1965)

by Måns Bergkvist

Shamanism and psychedelics in evolutionary perspective

Exploring MDMA for addictions

by Dr. Ben Sessa

_____________________

And more...